3.75 USD
-0.16 (-4.09%)
3.99 USD
+0.24 (+6.4%)
TVRD Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Faruqi & Faruqi, LLP
3 days ago - By: Faruqi & Faruqi LLP
11 days ago - By: Faruqi & Faruqi, LLP
12 days ago - By: Faruqi & Faruqi LLP
14 days ago - By: Zacks Investment Research
14 days ago - By: Tvardi Therapeutics, Inc.
18 days ago - By: Faruqi & Faruqi, LLP
19 days ago - By: Tvardi Therapeutics, Inc.
20 days ago - By: Schall Law
23 days ago - By: Faruqi & Faruqi LLP
a month ago - By: Faruqi & Faruqi, LLP
a month ago - By: Schall Law
a month ago - By: Faruqi & Faruqi LLP
a month ago - By: Tvardi Therapeutics, Inc.
a month ago - By: Faruqi & Faruqi, LLP
a month ago - By: The Schall Law Firm
a month ago - By: Faruqi & Faruqi LLP
a month ago - By: Faruqi & Faruqi, LLP
a month ago - By: Faruqi & Faruqi LLP
a month ago - By: The Rosen Law Firm, P.A.
a month ago - By: Faruqi & Faruqi, LLP
2 months ago - By: Faruqi & Faruqi, LLP
2 months ago - By: Faruqi & Faruqi, LLP
2 months ago - By: Benzinga
2 months ago - By: Tvardi Therapeutics, Inc.
3 months ago - By: Tvardi Therapeutics, Inc.
4 months ago - By: The Motley Fool
4 months ago - By: Tvardi Therapeutics, Inc.
5 months ago - By: Tvardi Therapeutics, Inc.